Skip to content
1st Counsel – Lifestyle
Author:
Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
November 12, 2026
Bolt Biotherapeutics to Participate in Upcoming Conferences
November 3, 2026
Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications
October 23, 2026
Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 11, 2026